YUHSpace

BROWSE

Export

Cited 1 times in

2024 KSoLA consensus on secondary dyslipidemia

DC Field Value Language
dc.contributor.author이상학-
dc.date.accessioned2024-12-06T01:49:58Z-
dc.date.available2024-12-06T01:49:58Z-
dc.date.issued2024-09-
dc.identifier.issn1226-3303-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/200615-
dc.description.abstractElevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Association of Internal Medicine-
dc.relation.isPartOfKOREAN JOURNAL OF INTERNAL MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHBiomarkers / blood-
dc.subject.MESHConsensus*-
dc.subject.MESHDyslipidemias* / blood-
dc.subject.MESHDyslipidemias* / diagnosis-
dc.subject.MESHDyslipidemias* / drug therapy-
dc.subject.MESHDyslipidemias* / therapy-
dc.subject.MESHHumans-
dc.subject.MESHHypercholesterolemia / blood-
dc.subject.MESHHypercholesterolemia / complications-
dc.subject.MESHHypercholesterolemia / diagnosis-
dc.subject.MESHHypercholesterolemia / drug therapy-
dc.subject.MESHHypertriglyceridemia / blood-
dc.subject.MESHHypertriglyceridemia / diagnosis-
dc.subject.MESHHypertriglyceridemia / therapy-
dc.subject.MESHHypolipidemic Agents* / therapeutic use-
dc.subject.MESHRisk Factors-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHTriglycerides / blood-
dc.title2024 KSoLA consensus on secondary dyslipidemia-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorHoyoun Won-
dc.contributor.googleauthorJae Hyun Bae-
dc.contributor.googleauthorHyunjung Lim-
dc.contributor.googleauthorMinji Kang-
dc.contributor.googleauthorMinjoo Kim-
dc.contributor.googleauthorSang-Hak Lee-
dc.contributor.googleauthoron behalf of the Clinical Practice Guidelines Committee, Korean Society of Lipid and Atherosclerosis (KSoLA)-
dc.identifier.doi10.3904/kjim.2024.156-
dc.contributor.localIdA02833-
dc.relation.journalcodeJ02883-
dc.identifier.eissn2005-6648-
dc.identifier.pmid39252486-
dc.subject.keywordDiagnosis-
dc.subject.keywordDrug-related side effects and adverse reactions-
dc.subject.keywordFood-
dc.subject.keywordLipoproteins-
dc.subject.keywordMetabolism-
dc.contributor.alternativeNameLee, Snag Hak-
dc.contributor.affiliatedAuthor이상학-
dc.citation.volume39-
dc.citation.number5-
dc.citation.startPage717-
dc.citation.endPage730-
dc.identifier.bibliographicCitationKOREAN JOURNAL OF INTERNAL MEDICINE, Vol.39(5) : 717-730, 2024-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links